Mutations in fusA associated with posttherapy fusidic acid resistance in Clostridium difficile
(2007) In Antimicrobial Agents and Chemotherapy 51(5). p.1840-1843- Abstract
- In silico, we identified fusA (2,067 bp) in Clostridium difficile 630. Sequencing of fusA in posttherapy fusidic acid-resistant C. difficile isolates from 12 patients with C. difficile-associated diarrhea (CDAD) identified fusA mutations, one or two nonsynonymous substitutions, or in one case a deletion of one codon associated with resistance. Five of these mutations have previously been described in fusA of fusidic acid-resistant Staphylococcus aureus, but seven were novel fusA mutations. Fusidic acid monotherapy for CDAD seemed to rapidly select conserved resistant mutants.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/659722
- author
- Noren, T. ; Akerlund, T. ; Wullt, Marlene LU ; Burman, L. G. and Unemo, M.
- organization
- publishing date
- 2007
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Antimicrobial Agents and Chemotherapy
- volume
- 51
- issue
- 5
- pages
- 1840 - 1843
- publisher
- American Society for Microbiology
- external identifiers
-
- wos:000246541500038
- scopus:34248367707
- ISSN
- 1098-6596
- DOI
- 10.1128/AAC.01283-06
- language
- English
- LU publication?
- yes
- id
- 1fe0b184-a5b6-415a-ac27-7d4bf16dfb92 (old id 659722)
- alternative location
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17307985&dopt=Abstract
- date added to LUP
- 2016-04-01 16:58:39
- date last changed
- 2022-02-28 00:59:20
@article{1fe0b184-a5b6-415a-ac27-7d4bf16dfb92, abstract = {{In silico, we identified fusA (2,067 bp) in Clostridium difficile 630. Sequencing of fusA in posttherapy fusidic acid-resistant C. difficile isolates from 12 patients with C. difficile-associated diarrhea (CDAD) identified fusA mutations, one or two nonsynonymous substitutions, or in one case a deletion of one codon associated with resistance. Five of these mutations have previously been described in fusA of fusidic acid-resistant Staphylococcus aureus, but seven were novel fusA mutations. Fusidic acid monotherapy for CDAD seemed to rapidly select conserved resistant mutants.}}, author = {{Noren, T. and Akerlund, T. and Wullt, Marlene and Burman, L. G. and Unemo, M.}}, issn = {{1098-6596}}, language = {{eng}}, number = {{5}}, pages = {{1840--1843}}, publisher = {{American Society for Microbiology}}, series = {{Antimicrobial Agents and Chemotherapy}}, title = {{Mutations in fusA associated with posttherapy fusidic acid resistance in Clostridium difficile}}, url = {{http://dx.doi.org/10.1128/AAC.01283-06}}, doi = {{10.1128/AAC.01283-06}}, volume = {{51}}, year = {{2007}}, }